Blood test breakthrough could pinpoint hidden tumors
NCT ID NCT01022515
Summary
This study tested a new blood marker called EM66 to see if it could better identify rare adrenal tumors (pheochromocytoma/paraganglioma) that cause severe high blood pressure. Researchers compared EM66 levels in 60 people: some with these tumors and others with ordinary high blood pressure. The goal was to create a more accurate diagnostic tool to help doctors tell these dangerous tumors apart from common hypertension.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC 9301
Lille, 59000, France
-
CIC 9304
Paris, 75012, France
-
Cardiology Department
Paris, 75012, France
-
Cic-Crb 0204
Rouen, 76000, France
-
Endocrinology Department
Lille, 59000, France
-
Endocrinology Department
Rouen, 76000, France
-
Endocrinology Department, Gustave-Roussy Institute
Villejuif, 94000, France
-
Inserm U982/EA 4310; Rouen University (DC2N)
Mont-Saint-Aignan, 76800, France
Conditions
Explore the condition pages connected to this study.